Medicare's proposed dialysis cut takes a toll on device makers

July 2, 2013 by Arezu Sarvestani

Medical device makers DaVita and Fresenius suffer Wall Street losses amid Medicare's proposal to cut about 9% from dialysis reimbursements.

Updated July 2, 2013, at 3:45 p.m. with comment from NxStage Medical.

Updated July 2, 2013, at 5 p.m. with comment from Fresenius.

healthcare and spending

Dialysis technology makers slid hard today after the Center for Medicare & Medicaid Services proposed a reimbursement decrease of more than 9% for 2014.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.